Clinical Safety Study of the Application of CRIS100 in Participants With Acute Spinal Cord Injury
The goal of this clinical trial is to test CRIS100 treatment in participants with acute thoracic spinal cord injury. The main questions it aims to answer are:
safety of CRIS100
efficacy of CRIS100
Participants will receive 75 mcg CRIS100 in the epicenter of the spinal injury, within 72 hours of the trauma.
100 项与 CRIS-100 相关的专利(医药)